Apr 30, 2024 • 8:00 AM EDT In Vivo Efficacy of Matinas BioPharma’s Oral MAT2203 in Pulmonary Mucormycosis Published in Journal of Antimicrobial Agents and Chemotherapy
Mar 27, 2024 • 4:05 PM EDT Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update